PEREGRINE CAPITAL MANAGEMENT LLC Adaptive Biotechnologies Corporation Transaction History

PEREGRINE CAPITAL MANAGEMENT LLC portfolio value:

$1.98M
portfolio value

PEREGRINE CAPITAL MANAGEMENT LLC quarter portfolio value change:

-11.99%
quarter

Adaptive Biotechnologies Corporation 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -5.18% -15.22K shares -393K $7.12 278.73K
Q2 2022 share Decrease -7.60% -24.19K shares -2.03M $8.09 293.95K
Q1 2022 share Decrease -6.28% -21.31K shares -5.10M $13.88 318.14K
Q4 2021 share Increase +22.40% 62.11K shares 98K $28.33 339.46K
Q3 2021 share Decrease -13.85% -44.57K shares -3.72M $33.99 277.34K
Q2 2021 share Increase +13.24% 37.62K shares 1.70M $40.86 321.92K
Q1 2021 share Decrease -4.22% -12.51K shares -6.10M $40.26 284.29K
Q4 2020 share Decrease -9.30% -30.42K shares 1.63M $59.13 296.80K
Q3 2020 share Decrease -12.28% -45.81K shares -2.13M $48.63 327.23K
Q2 2020 share Decrease -3.25% -12.54K shares 7.33M $48.38 373.04K
Q1 2020 share Increase +30.47% 90.04K shares 1.86M $27.78 385.59K
Q4 2019 share Increase 0.00% 295.54K shares 8.84M $29.92 295.54K